Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer

Background and purpose: This paper investigates the outcome using different dose/fractionation schedules in high dose rate (HDR) post-operative vaginal vault radiotherapy in patients with low to intermediate risk endometrial cancer. Materials and methods: The world literature was reviewed and thirte...

Full description

Saved in:
Bibliographic Details
Published in:Radiotherapy and oncology 2000-07, Vol.56 (1), p.17-22
Main Authors: Pearcey, Robert G, Petereit, Daniel G
Format: Article
Language:English
Subjects:
Brachytherapy
Clinical Trials as Topic
Dose Fractionation, Radiation
Endometrial cancer
Endometrial Neoplasms - radiotherapy
Endometrial Neoplasms - surgery
Female
Humans
Linear Models
Neoplasm Recurrence, Local - prevention & control
Neoplasm Recurrence, Local - radiotherapy
Vaginal Neoplasms - prevention & control
Vaginal Neoplasms - radiotherapy
Vault brachytherapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and purpose: This paper investigates the outcome using different dose/fractionation schedules in high dose rate (HDR) post-operative vaginal vault radiotherapy in patients with low to intermediate risk endometrial cancer. Materials and methods: The world literature was reviewed and thirteen series were analyzed representing 1800 cases. Results: A total of 12 vaginal vault recurrences were identified representing an overall vaginal control rate of 99.3%. A wide range of dose fractionation schedules and techniques have been reported. In order to analyze a dose response relationship for tumor control and complications, the biologically effective doses to the tumor and late responding tissues were calculated using the linear quadratic model. A threshold was identified for complications, but not vaginal control. While dose fractionation schedules that delivered a biologically effective dose to the late responding tissues in excess of 100 Gy 3 (LQED=60 Gy) predicted for late complications, dose fractionation schedules that delivered a modest dose to the vaginal surface (50 Gy 10 or LQED=30 Gy) appeared tumoricidal with vaginal control rates of at least 98%. Conclusions: By using convenient, modest dose fractionation schedules, HDR vaginal vault – brachytherapy yields very high local control and extremely low morbidity rates.
ISSN:0167-8140
1879-0887
DOI:10.1016/S0167-8140(00)00171-7